These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8674073)

  • 1. Hyaluronate-independent metastatic behavior of CD44 variant-expressing pancreatic carcinoma cells.
    Sleeman JP; Arming S; Moll JF; Hekele A; Rudy W; Sherman LS; Kreil G; Ponta H; Herrlich P
    Cancer Res; 1996 Jul; 56(13):3134-41. PubMed ID: 8674073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastasis suppression by the standard CD44 isoform does not require the binding of prostate cancer cells to hyaluronate.
    Gao AC; Lou W; Sleeman JP; Isaacs JT
    Cancer Res; 1998 Jun; 58(11):2350-2. PubMed ID: 9622073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.
    Liao HX; Levesque MC; Patton K; Bergamo B; Jones D; Moody MA; Telen MJ; Haynes BF
    J Immunol; 1993 Dec; 151(11):6490-9. PubMed ID: 7504022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of antisense CD44 variant 6 inhibits colorectal tumor metastasis and tumor growth in a wound environment.
    Reeder JA; Gotley DC; Walsh MD; Fawcett J; Antalis TM
    Cancer Res; 1998 Aug; 58(16):3719-26. PubMed ID: 9721884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the hyaluronan receptors CD44 and RHAMM in human pancreatic cancer cells.
    Abetamann V; Kern HF; Elsässer HP
    Clin Cancer Res; 1996 Sep; 2(9):1607-18. PubMed ID: 9816340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.
    Ahrens T; Sleeman JP; Schempp CM; Howells N; Hofmann M; Ponta H; Herrlich P; Simon JC
    Oncogene; 2001 Jun; 20(26):3399-408. PubMed ID: 11423990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A link between ras and metastatic behavior of tumor cells: ras induces CD44 promoter activity and leads to low-level expression of metastasis-specific variants of CD44 in CREF cells.
    Hofmann M; Rudy W; Günthert U; Zimmer SG; Zawadzki V; Zöller M; Lichtner RB; Herrlich P; Ponta H
    Cancer Res; 1993 Apr; 53(7):1516-21. PubMed ID: 8453616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal and central regions of the human CD44 extracellular domain participate in cell surface hyaluronan binding.
    Liao HX; Lee DM; Levesque MC; Haynes BF
    J Immunol; 1995 Oct; 155(8):3938-45. PubMed ID: 7561101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 hyaluronate binding influences growth kinetics and tumorigenicity of human colon carcinomas.
    Takahashi K; Stamenkovic I; Cutler M; Saya H; Tanabe KK
    Oncogene; 1995 Dec; 11(11):2223-32. PubMed ID: 8570172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 variant isoforms promote metastasis formation by a tumor cell-matrix cross-talk that supports adhesion and apoptosis resistance.
    Klingbeil P; Marhaba R; Jung T; Kirmse R; Ludwig T; Zöller M
    Mol Cancer Res; 2009 Feb; 7(2):168-79. PubMed ID: 19208744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM; Lesley JF; Hyman R
    Cancer Res; 1998 Aug; 58(16):3736-42. PubMed ID: 9721887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotides.
    Wallach SB; Friedmann A; Naor D
    Cancer Detect Prev; 2000; 24(1):33-45. PubMed ID: 10757121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 can be activated to function as an hyaluronic acid receptor in normal murine T cells.
    Lesley J; Hyman R
    Eur J Immunol; 1992 Oct; 22(10):2719-23. PubMed ID: 1382996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The two major CD44 proteins expressed on a metastatic rat tumor cell line are derived from different splice variants: each one individually suffices to confer metastatic behavior.
    Rudy W; Hofmann M; Schwartz-Albiez R; Zöller M; Heider KH; Ponta H; Herrlich P
    Cancer Res; 1993 Mar; 53(6):1262-8. PubMed ID: 8443806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirements for signal delivery through CD44: analysis using CD44-Fas chimeric proteins.
    Ishiwatari-Hayasaka H; Fujimoto T; Osawa T; Hirama T; Toyama-Sorimachi N; Miyasaka M
    J Immunol; 1999 Aug; 163(3):1258-64. PubMed ID: 10415022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of functional CD44 hyaluronan receptor on human NMYC-amplified neuroblastoma cells.
    Gross N; Balmas K; Brognara CB
    Cancer Res; 1997 Apr; 57(7):1387-93. PubMed ID: 9102228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD44 expression on activated B cells. Differential capacity for CD44-dependent binding to hyaluronic acid.
    Hathcock KS; Hirano H; Murakami S; Hodes RJ
    J Immunol; 1993 Dec; 151(12):6712-22. PubMed ID: 7505013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.
    Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB
    Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan facilitates invasion of colon carcinoma cells in vitro via interaction with CD44.
    Kim HR; Wheeler MA; Wilson CM; Iida J; Eng D; Simpson MA; McCarthy JB; Bullard KM
    Cancer Res; 2004 Jul; 64(13):4569-76. PubMed ID: 15231668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.